3.5. Statistical analysis
This protocol is extracted from research article:
Different moxibustion therapies for urinary retention after anorectal surgery
Medicine (Baltimore), Jan 15, 2021; DOI: 10.1097/MD.0000000000024132

Revman 5.3 software (Cochrane Collaboration) was used for bias evaluation. For continuous variables (time to first urination), the results will be reported as mean difference (MD) and 95% confidence interval (CI); count data (effective rate) will be compared by odds ratio (OR) and 95% CI are calculated. In the heterogeneity test, if I2 < 50%, P > .10, there is no significant heterogeneity. We chose the fixed effect model to combine the effect quantity. If the combined data is I2 > 50%, P < .10, it indicates high heterogeneity. We choose the random effect model to combine the effect quantity.[15]

Using Gemtc 0.14.3 (Developed by van Valkenhoef G et al) and Stata14.2 (STATA Corp., College Station, TX, USA) for mesh meta-analysis.[16,17] In Gemtc software, Bayesian mesh meta-analysis is realized by Markov Chain Monte Carlo (MCMC) method, through 4 chains. For simulation, the number of iterations is set to 50,000, and the step size is set to 10.[18] At the same time, the potential scale reduction parameter (potential scale reduced factor, PSRF) is used to evaluate the convergence of the results. When the PSRF is close to 1, it indicates that the results have good convergence and the obtained results are highly reliable.[19]

Note: The content above has been extracted from a research article, so it may not display correctly.

Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.

We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.